RSSL is an independent global leader at the forefront of scientific analysis, research, consultancy and training, serving the pharmaceutical, biopharmaceutical, healthcare, and personal care sectors. We apply leading edge science with passion and integrity to deliver enhanced value. Our multi-disciplinary teams provide rapid results, expert interpretation and sound advice to resolve our client’s issues. We are inspected by the MHRA, FDA which ensures that our analytical support is of the highest standard.
Our extensive range of services include:
• Analytical Services for Drug Formulation
• Biopharmaceutical Product Analysis
• Contamination – Chemical and Physical
• Cleaning Validation
• Extractables and Leachables
• Impurity Isolation and Sample Purification
• Medical Devices
• Method Development and Validation
• Microbiological Analysis
• Pharmaceutical Training
• Pharmacopoeial Testing to USP, EP, JP, CP
• Physical and Structural Properties
• Stability Storage, Management and Testing
We are trusted by industry to provide a solution with scientific excellence, outstanding customer service, and professionalism.
During a manufacturing process unexpected and unknown impurities may arise in a sample. It is important that such impurities are isolated and identified.
In an industry that is seeing increasing levels of outsourcing, the contract research organisation (CRO) needs to have proven experience in both the pragmatism and flexibility of method development and a regulatory background in validation.
Oral dosage forms remain one of the most flexible and effective treatments available to patients. Dissolution testing is a requirement for all solid oral dosage forms and is used throughout the development life-cycle for product release and stability testing. It is a pivotal analytical test used for detecting physical changes in an active pharmaceutical ingredient and formulated product
Sometimes it's the smallest details that have the biggest impact on pharmaceutical performance. That's certainly true when it comes down to the properties of particles and their impact on pharmaceutical performance. Subtle changes in particle size, shape and distribution can have a major impact on pharmaceutical solubility, stability and efficacy.
Cross contamination must be avoided in the pharmaceutical industry at all costs. Successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood. Areas of concern must be addressed to ensure a successful outcome across the entire process.